Effect of glycated low density lipoprotein on smooth muscle cell proliferation

International Angiology

Volumn 18, Issue 4, 1999, Pages 331-334

  Makita, T ^a   Tanaka, A ^a   Numano, F ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Cell division; Diabetes mellitus; Lipoprotein, LDL; Muscle, smooth, vascular

Indexed keywords

LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ARTICLE; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; GLYCATION; HUMAN; NONHUMAN; SMOOTH MUSCLE FIBER; SWINE;

ANIMALS; ARTERIOSCLEROSIS; CELL COUNT; CELL DIVISION; GLUCOSE; HUMANS; LIPOPROTEINS, LDL; MUSCLE, SMOOTH, VASCULAR; SWINE; TIME FACTORS;

EID: 0033502311     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Ross R. The pathogenesis of atherosclerosis, a perspective for the 1990s. Nature 1993;362:801-9.
2. Mii S, Ware JA, Kent KC. Transforming growth factor-beta inhibits human vascular smooth muscle cell growth and migration. Surgery 1993;114:464-70.
3. Powell RJ, Cronenwett JL, Fillinger MF, Wagner RJ. Effect of endothelial cells and transforming growth factor-beta 1 on cultured vascular smooth muscle cell growth patterns. J Vasc Surg 1994;20:787-94.
4. Majack RA. Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures. J Cell Biol 1987;105:465-71.
5. Koyama N, Morisaki N, Saito Y, Yoshida S. Regulatory effect of platelet-derived growth factor-AA homodimer on migration of vascular smooth muscle cells. J Biol Chem 1992;267:22806-12.
6. Koyama N, Koshikawa T, Morisaki N, Saito Y, Yoshida S. Bifunctional effects of transforming growth factor-AA on migration of cultured rat aortic smooth muscle cells. Biochem Biophys Res Comm 1990;169:725-9.
7. Lyons TJ. Glycation and oxidation: a role in the pathogenesis of atherosclerosis. Am J Cardiol 1993;71:26-31.
8. Plinski W, Tangirala RK, Miller E, Young SG, Witzum JL. Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. Arterioscler Thromb VasC Biol 1995;15: 1569-76.
9. Sakai M, Miyazaki A, Hakamata H, Sasaki T, Yui S, Yamazaki M et al. Lysophosphatidylcholine plays an essential role in the mitogenic effect of oxidized low density lipoprotein on murine macrophages. J Biol Chem 1994; 269:31430-5.
10. Yui S, Sasaki T, Miyasaki A, Horiuchi S, Yamazaki M. Induction of murine macrophage growth by modified LDLs. Arterioser Thromb 1993;13:331-7.
11. Wolff SP, Dean RT. Glucose autoxidation and protein modification. The potential role of autoxidative glycosylation in diabetes. Biochem J 1987;245:243-50.
12. Chatterjee S, Ghosh N. Oxidized low density lipoprotein stimulates aortic smooth muscle cell proliferation. Glycobiology 1996;6:303-11.
13. Chatterjee S. Role of oxidized human plasma low density lipoproteins in atherosclerosis: effects on smooth muscle cell proliferation. Mol Cell Biochem 1992;111: 143-7.
14. Mukhopadhyay CK, Ehrenwald E, Fox PL. Ceruloplasmin enhances smooth muscle cell and endothelial cell-mediated low density lipoprotein oxidation by a superoxide-dependent mechanism. J Biol Chem 1996;271: 14773-8.
15. Lyons TJ. Lipoprotein glycation and its metabolic consequences. Diabetes 1992;41:67-73.
16. Mullarkey CJ, Edelstein D, Brownlee M. Free radical generation by early glycation products: a mechanism for accelerated atherosclerosis in diabetes. Biochem Biophys Res Comm 1990;173:932-9.
17. Schleicher E, Olgemoller B, Schon J, Durst T, Wieland OH. Limited nonenzymatic glycosylation of low-density lipoprotein does not alter its catabolism in tissue culture. Biochem Biophys Acta 1985;846:226-33.
18. Gonen B, Basenziger J, Schonfeld G, Jacobsen D, Farrar P. Non-enzymatic glycosylation of low density lipoproteins in vitro. Effects on cell-interactive properties. Diabetes 1981;30:875-8.
19. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;34: 1345-53.
20. Waterborg JH, Matthews HR. The Lowry methods for protein quantitation. Methods Mol Biol 1994;32:1-4.
21. Okazaki M, Sasamoto K, Muramatsu T, Hosaki S. Analysis of plasma lipoproteins by gel permeation chromatography. In: Rifai N, Russel Warnich G, Dominiczah MH, editors. Handbook of lipoprotein testing. Washington DC: AACC Press, 1997:531-48.
22. Tanaka A, Yui K, Tomie N, Baba T, Tamura M, Makita T et al. A new assay method for glycated lipoproteins by high performance liquid chromatography. Ann N Y Acad Sci 1997;811:385-94.
23. Sakurai T, Kimura S, Nakano M, Kimura H. Oxydative modification of glycated low density lipoprotein in the presence of iron. Biochem Biophys Res Commun 1991;177:433-9.
24. Kishi Y, Watanabe T, Makita T, Sakita S, Watanabe R, Ashikaga T et al. Effect of Nifedipine on Cyclic GMP Turnover in Cultured Coronary Smooth Muscle Cells. J Cardiovasc Pharmacol 1995;26:590-5.
25. Ross R. The smooth muscle cell. Growth of smooth muscle cells in culture and formation of elastin fibers. J Cell Biol 1971;50:172-86.
26. Ishiyama H, Shiga M, Sasamoto K, Mizoguchi M, Pingang H. A new sulfonated tetrazolium salt that produces a highly water-soluble formazan dye. Chem Pharm Bull 1993;41:1118-22.
27. Colaco CA, Roser BJ. Atherosclerosis and glycation. Bioassays 1994;16:145-7.
28. McFarland KF, Catalan EW, Day JF, Thorpe SR, Baynes JW. Non-enzymatic glucosylation of serum proteins in diabetes mellitus. Diabetes 1979;28:1011-4.
29. Bucala R, Makita Z, Vega G, Grundy S, Koschinsky T, Cerami A et al. Modification of low density lipoprotein by advanced glycation end products contributes to dyslipidemia of diabetes and renal insufficiency. Proc Natl Acad Sci USA 1994;91:9441-5.
30. Bucala R, Makila Z, Koschinsky T, Cerami A, Vlassara H. Lipid advanced glycosylation: Patway for lipid oxidation in vivo. Proc Natl Acad Sci USA 1993;90:6434-8.
31. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988;318:1315-21.
32. Shea EA, Cohen MP. Immunologic detection and measurement of glycated apolipoprotein B with site specific monoclonal antibodies. J Immunol Methods 1993;162:85-95.
33. Steinbrecher UP, Witztum JL. Glucosylation of low density lipoprotein to an extent comparable to that seen in diabetes slows their catabolism. Diabetes 1984;33:130-4.
34. Lyons TJ. Oxidized low density lipoproteins - a role in the pathogenesis of atherosclerosis in diabetes? Diabetic Med 1991;8:411-9.
35. Lopes-Virella MF, Virella G. Modified lipoproteins, cytokines and macrovascular disease in non-insulin-dependent diabetes mellitus. Ann Med 1996;28:347-54.